BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11641777)

  • 21. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
    Wang L; Yang L; Luo Y; Zheng Y
    J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1.
    Bousquet E; Mazières J; Privat M; Rizzati V; Casanova A; Ledoux A; Mery E; Couderc B; Favre G; Pradines A
    Cancer Res; 2009 Aug; 69(15):6092-9. PubMed ID: 19602596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a monoclonal antibody specific for the Ras-related GTP-binding protein Rho A.
    Lang P; Gesbert F; Thiberge JM; Troalen F; Dutartre H; Chavrier P; Bertoglio J
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1522-8. PubMed ID: 8250908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of human tumors for rhoA mutations.
    Moscow JA; He R; Gnarra JR; Knutsen T; Weng Y; Zhao WP; Whang-Peng J; Linehan WM; Cowan KH
    Oncogene; 1994 Jan; 9(1):189-94. PubMed ID: 8302578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of Ras-related RhoB protein expression during the cell cycle.
    Zalcman G; Closson V; Linarès-Cruz G; Lerebours F; Honoré N; Tavitian A; Olofsson B
    Oncogene; 1995 May; 10(10):1935-45. PubMed ID: 7539118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53.
    Shi Q; Huang S; Jiang W; Kutach LS; Ananthaswamy HN; Xie K
    Cancer Res; 1999 May; 59(9):2072-5. PubMed ID: 10232590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation.
    Khosravi-Far R; Solski PA; Clark GJ; Kinch MS; Der CJ
    Mol Cell Biol; 1995 Nov; 15(11):6443-53. PubMed ID: 7565796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-induced nitric oxide synthase gene transcription is blocked by the heat shock response in human liver cells.
    de Vera ME; Wong JM; Zhou JY; Tzeng E; Wong HR; Billiar TR; Geller DA
    Surgery; 1996 Aug; 120(2):144-9. PubMed ID: 8751576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors.
    Reveneau S; Arnould L; Jolimoy G; Hilpert S; Lejeune P; Saint-Giorgio V; Belichard C; Jeannin JF
    Lab Invest; 1999 Oct; 79(10):1215-25. PubMed ID: 10532585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RhoA-GDP regulates RhoB protein stability. Potential involvement of RhoGDIalpha.
    Ho TT; Merajver SD; Lapière CM; Nusgens BV; Deroanne CF
    J Biol Chem; 2008 Aug; 283(31):21588-98. PubMed ID: 18524772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of rho B expression in invasive carcinoma from head and neck cancer patients.
    Adnane J; Muro-Cacho C; Mathews L; Sebti SM; Muñoz-Antonia T
    Clin Cancer Res; 2002 Jul; 8(7):2225-32. PubMed ID: 12114424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice.
    Chen Z; Sun J; Pradines A; Favre G; Adnane J; Sebti SM
    J Biol Chem; 2000 Jun; 275(24):17974-8. PubMed ID: 10770919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmitoylated cysteine 192 is required for RhoB tumor-suppressive and apoptotic activities.
    Wang DA; Sebti SM
    J Biol Chem; 2005 May; 280(19):19243-9. PubMed ID: 15713677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalization of RhoA and RhoB GTPases in pleomorphic adenoma of the parotid.
    Carboni Sde S; Micheletti AM; Pinheiro NM; Lima NA; Moura CC; Cardoso FA; Crema VO
    Tissue Cell; 2014 Dec; 46(6):527-34. PubMed ID: 25454559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RhoA, RhoB and RhoC differentially regulate endothelial barrier function.
    Pronk MCA; van Bezu JSM; van Nieuw Amerongen GP; van Hinsbergh VWM; Hordijk PL
    Small GTPases; 2019 Nov; 10(6):466-484. PubMed ID: 28949796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential binding of RhoA, RhoB, and RhoC to protein kinase C-related kinase (PRK) isoforms PRK1, PRK2, and PRK3: PRKs have the highest affinity for RhoB.
    Hutchinson CL; Lowe PN; McLaughlin SH; Mott HR; Owen D
    Biochemistry; 2013 Nov; 52(45):7999-8011. PubMed ID: 24128008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases.
    Berenjeno IM; Núñez F; Bustelo XR
    Oncogene; 2007 Jun; 26(29):4295-305. PubMed ID: 17213802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse macrophages completely lacking Rho subfamily GTPases (RhoA, RhoB, and RhoC) have severe lamellipodial retraction defects, but robust chemotactic navigation and altered motility.
    Königs V; Jennings R; Vogl T; Horsthemke M; Bachg AC; Xu Y; Grobe K; Brakebusch C; Schwab A; Bähler M; Knaus UG; Hanley PJ
    J Biol Chem; 2014 Oct; 289(44):30772-30784. PubMed ID: 25213860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity.
    Lebowitz PF; Davide JP; Prendergast GC
    Mol Cell Biol; 1995 Dec; 15(12):6613-22. PubMed ID: 8524226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interaction between RhoB and the transcription factor DB1.
    Lebowitz PF; Prendergast GC
    Cell Adhes Commun; 1998; 6(4):277-87. PubMed ID: 9865462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.